|
- ipidacrine | Dosing Uses - medtigo
20 mg of ipidacrine given every 2-3 times day The duration of treatment in acute neuritis ranges from 10 to 15 days, whereas chronic neuritis can last up to 20 to 30 days The maximum single dose is 40 mg, while the daily maximum dose is 200 mg
- LEVEMIR® (insulin detemir injection), for subcutaneous use
LEVEMIR is a recombinant human insulin analog for once- or twice-daily subcutaneous administration Patients treated with LEVEMIR once-daily should administer the dose with the evening meal or at
- Package leaflet: Information for the patient NEIROMIDIN 5 mg ml . . .
Neiromidin 5 mg ml and Neiromidin 15 mg ml solution for injection are administered subcutaneously or intramuscularly In cases of peripheral nervous system diseases, myasthenia and myasthenic syndrome: 5-15
- Ipidacrine - Rompharm Company
The active substance in Ipidacrine Rompharm 5 mg ml or 15 mg ml, solution for injection, is a reversible cholinesterase inhibitor It directly stimulates impulse transmission at CNS and neuromuscular synapses by blocking membrane potassium channels
- IPIDACRINE - National Center for Advancing Translational Sciences
Dose and duration of treatment is determined individually depending on the severity of the disease Peripheral nervous system diseases: 10-20 mg; 1-3 times a day The treatment is 1 to 2 months
- AUVI-Q® (epinephrine injection, USP) for Healthcare Professionals
AUVI-Q® (epinephrine injection, USP) is indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to allergens, idiopathic and exercise-induced anaphylaxis AUVI-Q is intended for patients with a history of anaphylactic reactions or who are at increased risk for anaphylaxis
- Ipidacrin-BP inj. - Injectable solution | BalkanPharmaceuticals. com
Ipidacrine 5 mg ml is a medication that improves blood circulation and tissue oxygenation, used to treat cerebral ischemia, strokes, and other neurological conditions This medication is administered through intramuscular or subcutaneous injection, as prescribed by a physician Please read the leaflet before use
- Ipidacrine: Uses, Interactions, Mechanism of Action - DrugBank Online
Ipidacrine may increase the bradycardic activities of Alprenolol The therapeutic efficacy of Amantadine can be decreased when used in combination with Ipidacrine The risk or severity of adverse effects can be increased when Ipidacrine is combined with Amifampridine
|
|
|